United States v. Unified Judicial System of Pennsylvania
On January 31, 2024, the Unified Judicial System of Pennsylvania (UJS) agreed to pay $100,000 and to encourage all its component courts to adopt new policies to ensure that individuals under Pennsylvania state court supervision can take lawfully prescribed medications to treat opioid use disorder (OUD). The settlement agreement resolved the Justice Department's lawsuit against the UJS, the Supreme Court of Pennsylvania, and the Blair, Jefferson, Lackawanna and Northumberland County Courts of Common Pleas.
The United States filed its original complaint on February 24, 2022, asserting that UJS courts violated Title II of the ADA by implementing administrative policies categorically limiting or prohibiting the use of lawfully prescribed medication for the treatment of OUD by individuals in court supervision programs. The United States had previously notified the UJS that its courts had engaged in discrimination in a letter of findings issued on February 2, 2022. The District Court dismissed the United States' original complaint on April 21, 2023, without prejudice and the United States filed an amended complaint on May 22, 2023. A second motion to dismiss by the Defendants and an opposition filed by the United States were pending before the court at the time of resolution.